| Financial Year |
March 31 2023 |
| Monetary Funds |
9,450,517,507.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
473,946,818.74 |
| Accounts Receivable |
1,142,989,839.14 |
| Advances to Suppliers |
1,695,018,102.99 |
| Other Receivables |
73,145,111.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,786,484,918.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
297,979,090.55 |
| Total Current Assets |
18,684,196,466.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,059,570.20 |
| Investment Properties |
-- |
| Fixed Assetes |
8,732,214,228.35 |
| Under-construction Projects |
1,972,616,589.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,116,133,560.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
88,131,854.60 |
| Deferred Income Tax Assets |
146,277,892.35 |
| Other Non-Current Assets |
32,685,451.80 |
| Sub-Total of Non-Current Assets |
14,139,968,769.49 |
| Total Assets |
32,824,165,236.38 |
| Short-Term Loans |
1,197,653,926.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,987,117,933.18 |
| Accounts Payable |
2,569,888,161.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
89,491,445.99 |
| Taxes Payable |
98,880,051.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
334,375,815.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,989,425.42 |
| Other Current Liabilities |
442,710,319.73 |
| Sub-Total of Current Liabilities |
12,218,074,460.53 |
| Long-term Loans |
42,972,801.39 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
37,922,430.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
59,543,980.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
377,928,371.84 |
| Total Liabilities |
12,596,002,832.37 |
| Paid-In Capital(Or Share Stock) |
3,377,189,083.00 |
| Capital Surplus |
10,022,403,769.79 |
| Surplus Reserve |
857,879,066.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,955,706,701.94 |
| Minority Stockholder's Interest |
7,616,525.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,220,545,878.68 |
| Owner's Equity（Stockholder's Equity） |
20,228,162,404.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,824,165,236.38 |
